日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)

来自德国前瞻性 PARAGON（胰腺癌结果、生活质量和转化研究平台）注册研究（IKF-PARAGON 研究）的胰腺癌患者一线至三线治疗情况和生活质量数据

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70280
Goetze, Thorsten O; Al-Batran, Salah-Eddin; Liersch, Ruediger; Scheuer, Lars; Goehler, Thomas; Kaiser, Ulrich; Denzlinger, Claudio; Brandl, Stephan; Pink, Daniel; Uhlig, Jens; Maasberg, Michael; Loose, Maria; Schaaf, Marina; Sookthai, Disorn; Zäpf, Bianca; Pauligk, Claudia; Habibzade, Timursah; Hofheinz, Ralf-Dieter; Koch, Christine
胰腺癌
肿瘤
肿瘤免疫
AGO
发表日期：2026
文献求助 收藏

Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110)

评估基于炎症的改良格拉斯哥预后评分（mGPS）作为接受一线化疗的转移性结直肠癌患者的预后和预测生物标志物：随机 III 期 XELAVIRI 试验（AIO KRK0110）的事后分析

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103374
Boukovala, M; Modest, D P; Ricard, I; Fischer von Weikersthal, L; Decker, T; Vehling-Kaiser, U; Uhlig, J; Schenk, M; Freiberg-Richter, J; Peuser, B; Denzlinger, C; Peveling Genannt Reddemann, C; Graeven, U; Schuch, G; Schwaner, I; Heinrich, K; Neumann, J; Jung, A; Held, S; Stintzing, S; Heinemann, V; Michl, M
肿瘤
炎症
肠癌
肿瘤免疫
炎症/感染
发表日期：2024
文献求助 收藏

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients

基于仓库的、免疫肽组指导的个性化肽疫苗设计在慢性淋巴细胞白血病患者的临床试验评估中显示出可行性。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1482715
Heitmann, Jonas S; Jung, Susanne; Wacker, Marcel; Maringer, Yacine; Nelde, Annika; Bauer, Jens; Denk, Monika; Hoenisch-Gravel, Naomi; Richter, Marion; Oezbek, Melek T; Dubbelaar, Marissa L; Bilich, Tatjana; Pumptow, Marina; Martus, Peter; Illerhaus, Gerald; Denzlinger, Claudio; Steinbach, Francesca; Aulitzky, Walter-Erich; Müller, Martin R; Dörfel, Daniela; Rammensee, Hans-Georg; Salih, Helmut R; Walz, Juliane S
白血病
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116)

难治性转移性胰腺癌序贯治疗方案：5-FU/LV/伊立替康（FOLFIRI）与 5-FU/LV/奥沙利铂（OFF）的比较。PANTHEON 试验（AIO PAK 0116）

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-024-05827-x
Modest, Dominik Paul; Heinemann, Volker; Schütt, Philipp; Angermeier, Stefan; Haberkorn, Mike; Waidmann, Oliver; Graeven, Ullrich; Wille, Kai; Kunzmann, Volker; Henze, Larissa; Constantin, Christian; de Wit, Maike; Denzlinger, Claudio; Ballhausen, Alexej; Kurreck, Annika; Jelas, Ivan; Alig, Annabel Helga Sophie; Stahler, Arndt; Stintzing, Sebastian; Oettle, Helmut
胰腺癌
肿瘤
NTH
肿瘤免疫
发表日期：2024
文献求助 收藏

Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3

FOLFIRI联合西妥昔单抗与FOLFIRI联合贝伐珠单抗一线治疗RAS野生型转移性结直肠癌老年患者的疗效比较：一项基于FIRE-3随机试验的分析

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-022-01854-y
Fischer, Laura E; Stintzing, Sebastian; von Weikersthal, Ludwig Fischer; Modest, Dominik P; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas; Heinemann, Volker
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial

贝伐珠单抗为基础的序贯化疗与联合化疗治疗未治疗转移性结直肠癌的反应和疾病动态——XELAVIRI III期试验分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.751453
Kurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Heinrich, Kathrin; Held, Swantje; Stahler, Arndt; Alig, Annabel Helga Sophie; Jelas, Ivan; von Einem, Jobst C; Stintzing, Sebastian; Giessen-Jung, Clemens; Modest, Dominik P
肿瘤
肠癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.

基于免疫肽组学的慢性淋巴细胞白血病肽类免疫疗法的仓库设计

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.705974
Nelde Annika, Maringer Yacine, Bilich Tatjana, Salih Helmut R, Roerden Malte, Heitmann Jonas S, Marcu Ana, Bauer Jens, Neidert Marian C, Denzlinger Claudio, Illerhaus Gerald, Aulitzky Walter Erich, Rammensee Hans-Georg, Walz Juliane S
细胞生物学
白血病
发表日期：2021
文献求助 收藏

Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group

英夫利昔单抗（Remicade®）在低危骨髓增生异常综合征患者中的价值：欧洲癌症研究与治疗组织白血病组一项随机II期试验（EORTC 06023试验）的最终结果

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2011.044347
Baron, Frédéric; Suciu, Stefan; Amadori, Sergio; Muus, Petra; Zwierzina, Heinz; Denzlinger, Claudio; Delforge, Michel; Thyss, Antoine; Selleslag, Dominik; Indrak, Karel; Ossenkoppele, Gert; de Witte, Theo
白血病
肿瘤
肿瘤免疫
发表日期：2012
文献求助 收藏

Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity

小鼠肥大细胞释放前列腺素D2：代谢物形成对抑制增殖活性的重要性

期刊:Mediators of Inflammation
影响因子:4.2
doi:10.1080/09629359891216
Haberl, C; Hültner, L; Flügel, A; Falk, M; Geuenich, S; Wilmanns, W; Denzlinger, C
代谢
细胞生物学
肥大细胞
发表日期：1998
文献求助 收藏

Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat

白三烯受体拮抗剂FPL 55712、LY 163443和MK-571对大鼠体内半胱氨酰白三烯清除的影响

期刊:British Journal of Pharmacology
影响因子:7.7
doi:10.1111/j.1476-5381.1991.tb12268.x
Denzlinger, C; Grimberg, M; Kapp, A; Haberl, C; Wilmanns, W
Rat
信号转导
发表日期：1991
文献求助 收藏